Advanced Solid Malignancies Terminated Phase 1 Trials for Irinotecan (DB00762)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00473616Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and IrinotecanTreatment